Search

everythinglearnresearchcommunity

for

Search:↓

Proxalutamide helps COVID-19 patients get rid of the virus faster and recover quicker.

Testosterone's effects on COVID-19 are unclear and need more research.

Androgen deprivation therapy doesn't lower the risk of death from COVID-19 in prostate cancer patients.

Many people in Saudi Arabia experienced hair loss after COVID-19, especially women, those treated with antivirals, and those with a history of hair shedding.

Low ferritin and Vitamin D levels may cause hair loss after COVID-19.

Maidenhair fern might help with COVID-19 symptoms, but it needs more testing.

COVID-19 infection can significantly cause temporary hair loss.

Nearly half of the studied men with long COVID had low testosterone, including younger men.

Some patients on immunosuppressants had a weaker immune response to the Sinovac-CoronaVac COVID-19 vaccine.

COVID-19 can cause hair loss, and treatments like PRP and stem cells might help.

COVID-19 diagnosis is linked to new or worsening hair diseases, with stress from the pandemic likely contributing.

Some COVID-19 patients have skin issues, with men, ICU patients, and those on multiple antibiotics at higher death risk; in-person skin checks by dermatologists are more effective.

An 8-year-old boy developed a rare condition after a liver transplant, which improved after changing his medication.

Women with type D personality and PCOS experience more stress and use less effective coping strategies.

Hormone replacement therapy may lower the risk of severe COVID-19 outcomes in non-immunosuppressed people and male organ transplant recipients.

Many people experienced hair loss after having COVID-19, with the worst cases in hospitalized patients, and some saw hair regrowth within six months.

COVID-19 infection can cause temporary hair loss due to stress, treatment drugs, psychological impact, and pandemic-related stress.

Maidenhair fern extract might help treat COVID-19 symptoms, but more research is needed.

Maidenhair fern extract may help treat COVID-19 symptoms.

Dutasteride treatment in men with mild to moderate COVID-19 reduced viral shedding, inflammation, and recovery time without serious side effects.

The Polish medical societies have redefined metabolic syndrome and recommend lifestyle changes, certain medications, and possibly bariatric surgery for treatment. They also discuss managing related health conditions.

Sex hormones like estrogen and testosterone may affect COVID-19 severity differently in men and women, potentially influencing prevention and treatment strategies.

Some recovered COVID-19 patients experience skin, hair, and nail issues, suggesting they need follow-up care.

COVID-19 can cause temporary hair loss, often starting around 7-8 weeks after recovery, with factors like Vitamin D deficiency, other diseases, medication, and stress potentially contributing.

The treatment might help COVID-19 related hair loss, but more research is needed.

COVID-19 can cause various skin issues in children, mostly not severe, with chilblain-like lesions being common, especially in adolescents.

Teledermatology was popular among young adults and women, and high-resolution photos improved service during the pandemic.

Ruxolitinib significantly improves multiple autoimmune conditions in APS-1 patients.

The review found that current care models for PCOS are not fully effective and more research is needed, especially in low-income countries.

Polycystic ovary syndrome and iron overload share similar symptoms and can be potentially treated with blood removal, diet changes, and probiotics.